Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Assets (2019 - 2025)

Allogene Therapeutics (ALLO) has disclosed Return on Assets for 7 consecutive years, with 0.45% as the latest value for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.4% for FY2025, 4.0% up from the prior year.
  • Return on Assets hit 0.45% in Q4 2025 for Allogene Therapeutics, up from 0.46% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.17% in Q4 2021 to a low of 0.48% in Q2 2025.
  • Historically, Return on Assets has averaged 0.37% across 5 years, with a median of 0.44% in 2023.
  • Biggest five-year swings in Return on Assets: increased 10bps in 2021 and later decreased -22bps in 2022.
  • Year by year, Return on Assets stood at 0.17% in 2021, then plummeted by -130bps to 0.39% in 2022, then dropped by -18bps to 0.46% in 2023, then rose by 2bps to 0.45% in 2024, then fell by 0bps to 0.45% in 2025.
  • Business Quant data shows Return on Assets for ALLO at 0.45% in Q4 2025, 0.46% in Q3 2025, and 0.48% in Q2 2025.